RBC Europe’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $14K | Buy |
1,027
+395
| +63% | +$5.39K | ﹤0.01% | 466 |
|
|
2022
Q1 | $9K | Sell |
632
-152
| -19% | -$2.17K | ﹤0.01% | 540 |
|
|
2021
Q4 | $11K | Buy |
784
+281
| +56% | +$3.94K | ﹤0.01% | 522 |
|
|
2021
Q3 | $8.24K | Hold |
503
| – | – | ﹤0.01% | 972 |
|
|
2021
Q2 | $8.47K | Sell |
503
-493
| -49% | -$8.3K | ﹤0.01% | 986 |
|
|
2021
Q1 | $18.2K | Sell |
996
-189
| -16% | -$3.45K | ﹤0.01% | 795 |
|
|
2020
Q4 | $21.6K | Hold |
1,185
| – | – | ﹤0.01% | 697 |
|
|
2020
Q3 | $21.1K | Hold |
1,185
| – | – | ﹤0.01% | 638 |
|
|
2020
Q2 | $21.2K | Buy |
1,185
+189
| +19% | +$3.39K | ﹤0.01% | 617 |
|
|
2020
Q1 | $15.1K | Sell |
996
-781
| -44% | -$11.9K | ﹤0.01% | 606 |
|
|
2019
Q4 | $35.1K | Buy |
1,777
+369
| +26% | +$7.28K | ﹤0.01% | 532 |
|
|
2019
Q3 | $24.2K | Hold |
1,408
| – | – | ﹤0.01% | 590 |
|
|
2019
Q2 | $24.9K | Buy |
1,408
+412
| +41% | +$7.29K | ﹤0.01% | 605 |
|
|
2019
Q1 | $20.3K | Buy |
+996
| New | +$20.3K | ﹤0.01% | 644 |
|